Literature DB >> 18323675

Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations.

Mari Satoh1, Sayaka Ogikubo, Atsuko Yoshizawa-Ogasawara.   

Abstract

About 90% of patients with congenital nephrogenic diabetes insipidus (NDI) have vasopressin type 2 receptor (V2R) gene mutations that are inherited in an X-linked recessive manner. Although most female carriers are asymptomatic, some female carriers show polydipsia and polyuria. The reason why female carriers show NDI symptoms is explained by skewed X-inactivation. We studied X-inactivation patterns of six female carriers with heterozygote V2R gene mutations. The X-inactivation pattern in peripheral blood leukocytes was examined using methylation analysis of the polymorphic CAG repeat in the androgen receptor gene. Two asymptomatic female carriers showed random X-inactivation (61.9% and 60.7%). Skewed X-inactivation patterns (71.6%, 79.4%, and 91.2%) occurring preferentially to normal X alleles were recognized in three female carriers who showed clinical NDI symptoms. However, in one female carrier who showed clinical NDI symptoms, random X-inactivation (55.4%) was recognized. In conclusion, the clinical NDI phenotypes may correlate with the X-inactivation patterns in female carriers with heterozygote V2R gene mutations. However, in some female carriers, we cannot predict the clinical phenotypes by the evaluation of the X-inactivation patterns in peripheral blood leukocytes, because X-inactivation ratios within an individual are sometimes different between tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323675     DOI: 10.1507/endocrj.k07-083

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  12 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

2.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 3.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

Review 4.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

5.  Nephrogenic diabetes insipidus : Old deletion, new effect. A case report of a family from Greece.

Authors:  D Tramma; S Kalamitsou
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

Review 6.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

7.  A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.

Authors:  Li Zang; Yuping Gong; Yijun Li; Jingtao Dou; Zhaohui Lyu; Xiaoqing Su; Yawei Zhang; Yiming Mu
Journal:  Biomed Res Int       Date:  2022-07-12       Impact factor: 3.246

8.  Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Authors:  Sei Sasaki; Motoko Chiga; Eriko Kikuchi; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

Review 9.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

Review 10.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.